miR-671-5p Inhibits Tumor Proliferation by Blocking Cell Cycle in Osteosarcoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Osteosarcoma (OS) is an aggressive bone tumor common in young individuals.
• Molecular abnormalities, including microRNAs (miRNAs), are prevalent in OS.
• The specific role and mechanism of miR-671-5p in OS remain largely unknown.

Purpose of the Study:

• To investigate the role and mechanism of miR-671-5p in osteosarcoma.
• To determine if miR-671-5p functions as a tumor suppressor in OS.

Main Methods:

• Quantitative analysis of miR-671-5p expression in OS tissues and cells.
• In vivo and in vitro experiments to assess the effect of miR-671-5p overexpression on OS cell proliferation.
• Cell cycle analysis to evaluate the impact on cell cycle progression.
• Western blot and luciferase reporter assays to confirm direct binding of miR-671-5p to target genes.

Main Results:

• miR-671-5p was significantly downregulated in osteosarcoma tissues and cells.
• Overexpression of miR-671-5p suppressed OS cell proliferation both in vivo and in vitro.
• miR-671-5p induced cell cycle arrest.
• miR-671-5p directly targets and inhibits the expression of cyclin D1 (CCND1) and CDC34.
• CCND1 and CDC34 overexpression promoted OS cell proliferation and cell cycle progression, counteracting miR-671-5p effects.

Conclusions:

• miR-671-5p acts as a tumor suppressor in osteosarcoma.
• By targeting CCND1 and CDC34, miR-671-5p inhibits osteosarcoma development.
• miR-671-5p represents a potential novel therapeutic target for osteosarcoma.